Recent published studies have demonstrated the incremental value of the use of cell-free DNA for noninvasive prenatal testing with 100% sensitivity for trisomies 21 and 18 and a specificity of ≥99.7% ...
CHATSWORTH, Calif., Nov. 29, 2010 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and a provider of high value personalized ...
Multiple myeloma (MM) treatment has changed tremendously, with significant improvement in patient out-comes. One group with a suboptimal benefit is patients with high-risk cytogenetics, as tested by ...
New research shows that Optical Genome Mapping (OGM) detects abnormalities in chromosomes and DNA very quickly, effectively and accurately. Sometimes even better than all existing techniques together, ...
Effective diagnosis of genetic diseases depends on the skills of a multidisciplinary team with a wide range of clinical and laboratory experience. Three types of laboratory investigation can be ...
NEW HAVEN, Conn., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), along with its partner ADS Biotec announce the launch of the beta phase testing ...
MADISON, Wis.--(BUSINESS WIRE)-- Roche NimbleGen (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY) today announced that one of New Zealand’s largest medical laboratories has adopted the NimbleGen CGX ...
Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback